BIT 7.50% 3.7¢ biotron limited

Ann: BIT225 HIV-1 Immunomodulatory Paper Published, page-37

  1. 437 Posts.
    lightbulb Created with Sketch. 211
    not true. According to PhRMA (“the process behind new medicines”, 2015, online) , average clinical development time (from phases1 to 3) is around 6-7 years. Total time discovery to approval 10 years. So you’re well off the mark sorry. But I guess phrma data based on companies that know what they’re doing and are actually doing stuff. 15-20 years is probably about right when you have a company that’s a scientist’s hobby with job for life md.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.7¢
Change
-0.003(7.50%)
Mkt cap ! $33.38M
Open High Low Value Volume
3.8¢ 4.0¢ 3.7¢ $13.74K 361.7K

Buyers (Bids)

No. Vol. Price($)
1 421052 3.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.9¢ 19000 1
View Market Depth
Last trade - 15.39pm 05/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.